Vaccinium emarginatum

Vaccinium emarginatum · Accepted scientific name

Scientific literature: Very Sparse (0 studies) · ★☆☆☆☆

Vaccinium emarginatum, commonly known as the emarginate blueberry, is a resilient shrub native to various mountainous regions. Recent scientific investigations have turned their focus toward the complex biochemical properties found within the plant's underground structures. Specifically, researchers are exploring the therapeutic potential of the root nodule extract derived from this species. This study evaluates the efficacy of the extract when tested against the pathogenic bacterium Staphylococcus aureus. Understanding these interactions may reveal new pathways for utilizing plant-based compounds in combating bacterial infections.

Quick facts
Synonyms
Vaccinium Amamianum · Agapetes Emarginata
Common names
Not available
Family
Ericaceae
Distribution
Not available
Plant Parts
Root

Classification

Common Names

Vaccinium emarginatum is a unique botanical species known by several distinct common names across different linguistic contexts. In certain regions, it is referred to as オオバコケモモ, reflecting its specific local classification. It is also recognized by the descriptive Chinese names 凹葉越橘 and 凹顶越橘. Additionally, the plant is frequently identified as 凹顶越桔 in various botanical records. Understanding these multiple naming conventions is essential for accurate identification in the field.

Sources: Catalogue of Life (COL)

Synonyms

Vaccinium emarginatum is a botanical species that is frequently identified through various taxonomic designations. Within scientific literature, this plant is recognized by the synonym Agapetes emarginata. It is also documented under the alternative name Vaccinium amamianum, depending on the classification system used. These overlapping names reflect the evolving nature of botanical nomenclature and historical research. Understanding these relationships is essential for researchers seeking to accurately identify the species in different studies.

Sources: The World Checklist of Vascular Plants (WCVP)

Taxonomy

Vaccinium emarginatum belongs to the diverse kingdom Plantae, representing the vast biological world of green life. Within this kingdom, it is classified under the class Equisetopsida and the order Ericales. The plant further belongs to the Ericaceae family, which is known for its distinctive floral structures. It is specifically identified by its membership in the genus Vaccinium. Together, these taxonomic classifications provide a clear roadmap of its evolutionary heritage.

Rank Classification
Kingdom Plantae
Phylum Streptophyta
Class Equisetopsida
Subclass Magnoliidae
Order Ericales
Family Ericaceae
Genus Vaccinium

Sources: The World Checklist of Vascular Plants (WCVP)

Distribution

Geographic Regions

Vaccinium emarginatum is a specialized plant species with a distribution primarily centered within the Asia-Temperate region. Its natural range extends through various parts of Eastern Asia, showcasing a distinct ecological presence in these landscapes. Specifically, the species can be found thriving across the Nansei-shoto islands. Furthermore, its habitat encompasses the diverse terrain of Taiwan. This geographical spread highlights the plant's significant role within the temperate ecosystems of East Asia.

Sources: The World Checklist of Vascular Plants (WCVP)

Identification

Morphology

Vaccinium emarginatum grows in a sturdy shrub form that allows it to thrive in various habitats. Because of this structure, the plant is entirely self-supporting and maintains its shape without the need for external assistance.

Sources: Global Inventory of Floras and Traits (GIFT)

Biological Activities

Compounds

Vaccinium emarginatum is a medicinal plant that has a long history of use in Taiwanese ethnopharmacy. Recent phytochemical investigations into its root nodules have successfully isolated several key bioactive compounds. Specifically, the plant contains the flavonoids catechin and epicatechin, along with hyperin and isoquercetin. Additionally, the triterpenoid lupeol was identified as a significant constituent of the species. These diverse chemical components highlight the potential of the plant for future pharmaceutical research in anti-cancer and anti-bacterial applications.

Conditions

Vaccinium emarginatum demonstrates significant therapeutic potential through its bioactive constituents found in its root nodule extract. The plant exhibits anti-bacterial properties by treating Staphylococcus aureus via compounds such as procyanidins and isoquercetin. It also shows anti-cancer efficacy against gastric adenocarcinoma (AGS) through the action of procyanidin B3, A1, and isoquercetin. Furthermore, the plant effectively treats hepatocellular carcinoma (HepG2) using several identified phytochemicals. Finally, its ability to treat lung carcinoma (A549) is supported by the strong anti-proliferative activity of isoquercetin and the inhibitory effects of lupeol.

Preparations

Vaccinium emarginatum is prepared as a root nodule extract to evaluate its potential medicinal properties. Researchers utilized this specific extract to identify various bioactive chemical constituents through advanced analytical techniques. The investigation focused on the anti-cancer and anti-bacterial activities present within the processed root nodules. By analyzing the ethyl acetate fraction of the extract, scientists isolated several compounds like isoquercetin and various procyanidins. This preparation method serves as a foundation for exploring the plant's utility in pharmaceutical research.

Parts used

Vaccinium emarginatum is a medicinal plant with a long history of use in the ethnopharmacy of Taiwan. Recent scientific investigations have focused specifically on the bioactive extracts derived from the root nodule of this species. Through advanced chemical analysis, researchers have successfully isolated several important phytochemicals, including various procyanidins and triterpenoids, from the plant's root. These specific compounds have demonstrated significant potential in inhibiting the proliferation of several cancer cell lines, such as hepatocellular carcinoma. Ultimately, the study of the Vaccinium emarginatum root provides a promising foundation for developing new natural anti-cancer and anti-bacterial pharmaceutical agents.